Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Health Network, Toronto | OTHER |
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the surgical technique used in Abdominal Normothermic Regional Perfusion (A-NRP) in death determination by circulatory criteria (DCC) organ donors. The proposed study will demonstrate that there is no resumption of brain blood flow or activity during the A-NRP procedure. This will be assessed using multimodal neuromonitoring protocol that enables continuous focused monitoring of brain blood flow and activity during A-NRP. This will provide evidence that brain blood flow and activity does not resume during NRP and ensure donor safety in using this technique in standard of care practice.
This will be a multi-centre prospective observational cohort study that will enroll eligible DCC donors at participating donation hospitals. Participating programs will implement the A-NRP processes and organ recovery at the donation sites. Neurocritical care teams and donation physicians at the donation site and independent of transplant teams will implement neuromonitoring using the following modalities:
The neuromonitoring team will interpret observed signals in real-time during the A-NRP process. This study will confirm whether current A-NRP surgical safeguards ensure maintenance of permanent cessation of brain blood flow and/or activity during A-NRP and will guide the adoption of A-NRP in Ontario.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DCC Donors | Standard criteria DCC donors will be undergoing the A-NRP perfusion process to recondition organs prior to procurement. Multimodal neuromonitors will be placed on the donor prior to withdrawal of life support and readings will be recorded during the withdrawal process and for the duration of the A-NRP perfusion process. The neuromonitoring team will be looking for evidence of brain blood flow or activity. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neuromonitoring | Other | Multimodal neuromonitoring will include: Transcranial colour-coded Doppler (TCCD), Electroencephalography (EEG), and Somatosensory evoked potentials (SSEP) or brainstem auditory evoked potentials (BAEP) |
| Measure | Description | Time Frame |
|---|---|---|
| Donor resumption of brain blood flow and/or activity | Proportion of enrolled patients who have resumption of brain blood flow and/or activity during A-NRP on any neuromonitor and that is confirmed by neurocritical care physician and that results in termination of A-NRP | Through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Donor accrual rate | Number of eligible donors who are enrolled in the study and complete study procedures | Through study completion, an average of 1 year |
| Consent rate | Number of donors who consent to study procedures divided by the number of donors approached for study consent (target ≥ 80%) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients in critical care at participating study centers who qualify for DCC organ donation and whose families/surrogate decision makers have consented to DCC organ donation according to current criteria of the participating transplant programs.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Crystal Engelage, PhD | Contact | 519-685-8500 | 37517 | Crystal.Engelage@lhsc.on.ca |
| Anton Skaro, MD PhD | Contact | 519-663-2904 | Anton.Skaro@lhsc.on.ca |
| Name | Affiliation | Role |
|---|---|---|
| Anton Skaro, MD PhD | London Health Sciences Centre/Lawson Health Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| London Health Sciences Centre | Recruiting | London | Ontario | N6A 5A5 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Through study completion, an average of 1 year |
| Neuromonitoring modalities | Number of neuromonitoring modalities used per patient and reasons for excluding specific modalities | Through study completion, an average of 1 year |
| Duration and proportion of neuromonitoring signal | Duration of continuous neuromonitoring and proportion of total recording time with adequate signal per patient (velocity waveforms for TCCD, uv/mm for EEG, brainstem auditory evoked potentials (BAEP) signal, and somatosensory evoked potentials (SSEP) signal) | Through study completion, an average of 1 year |
| Neuromonitoring failure | Proportion of enrolled patients who had failure of neuromonitoring equipment during recording | Through study completion, an average of 1 year |
| Toronto Western Hospital | Not yet recruiting | Toronto | Ontario | M5T 2S8 | Canada |
|